Hypertension, use of antihypertensive medications and breast cancer survival among Black women
Mollie E Barnard, Nuo N Xu, Etienne X Holder, Dennis Jones, Matthew Nayor, Naomi Y Ko, Julie R Palmer · 2026
Read Hypertension, use of antihypertensive medications and breast cancer survival among Black women by Mollie E Barnard, Nuo N Xu, Etienne X Holder, Dennis Jones, Matthew Nayor, Naomi Y Ko, Julie R Palmer (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13471382.txt.
Description
Barnard and co-authors asked whether high blood pressure, and whether it is treated, changes survival after breast cancer among Black women in the United States. Their 2026 analysis drew on 2,474 participants in the Black Women's Health Study who developed invasive breast cancer.
Overall, untreated hypertension showed no clear survival link, but treated hypertension came with a hazard ratio of 0.81 against no hypertension, hinting at lower breast cancer death risk. The split by tumor type was sharper: among estrogen-receptor-positive cases, treated hypertension carried a hazard ratio of 0.53 for breast cancer death. Among receptor-negative cases, untreated hypertension instead doubled the risk, with a hazard ratio of 2.19 recorded. The authors stress that trials are needed to prove the treatment itself causes the benefit.
Catalog record
| CREATOR | Mollie E Barnard, Nuo N Xu, Etienne X Holder, Dennis Jones, Matthew Nayor, Naomi Y Ko, Julie R Palmer |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |